IL-1β Disrupts Postnatal Lung Morphogenesis in the Mouse

Pulmonary inflammation and increased production of the inflammatory cytokine IL-1β are associated with the development of bronchopulmonary dysplasia (BPD) in premature infants. To study the actions of IL-1β in the fetal and newborn lung in vivo, we developed a bitransgenic mouse in which IL-1β is expressed under conditional control in airway epithelial cells. Perinatal pulmonary expression of IL-1β caused respiratory insufficiency that was associated with increased postnatal mortality. While intrauterine growth of IL-1β–expressing mice was normal, their postnatal growth was impaired. IL-1β disrupted alveolar septation and caused abnormalities in α-smooth muscle actin and elastin deposition in the septa of distal airspaces. IL-1β disturbed capillary development and inhibited the production of vascular endothelial growth factor in the lungs of infant mice. IL-1β induced the expression of CXC chemokines KC (CXCL1) and macrophage inflammatory protein-2 (CXCL2) and of CC chemokines monocyte chemotactic protein...

[1]  K. Wada,et al.  Bombesin inhibits alveolarization and promotes pulmonary fibrosis in newborn mice. , 2006, American journal of respiratory and critical care medicine.

[2]  R. Simon,et al.  Expression of the reverse tetracycline-transactivator gene causes emphysema-like changes in mice. , 2006, American journal of respiratory cell and molecular biology.

[3]  P. Dekoninck,et al.  Growth of pulmonary microvasculature in ventilated preterm infants. , 2006, American journal of respiratory and critical care medicine.

[4]  J. Whitsett,et al.  Conditional recombination reveals distinct subsets of epithelial cells in trachea, bronchi, and alveoli. , 2005, American journal of respiratory cell and molecular biology.

[5]  H. Kurihara,et al.  Temporal Expression of Alpha–Smooth Muscle Actin and Drebrin in Septal Interstitial Cells during Alveolar Maturation , 2005, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[6]  B. Vohr,et al.  Vitamin A Supplementation for Extremely Low Birth Weight Infants: Outcome at 18 to 22 Months , 2005, Pediatrics.

[7]  J. Tichelaar,et al.  Interleukin-1beta causes pulmonary inflammation, emphysema, and airway remodeling in the adult murine lung. , 2005, American journal of respiratory cell and molecular biology.

[8]  A. Tanswell,et al.  Opposing effects of 60% oxygen and neutrophil influx on alveologenesis in the neonatal rat. , 2004, American journal of respiratory and critical care medicine.

[9]  H. Coxson,et al.  Early emphysema in patients with anorexia nervosa. , 2004, American journal of respiratory and critical care medicine.

[10]  U. Pastorino,et al.  Primary human alveolar type II epithelial cell chemokine release: effects of cigarette smoke and neutrophil elastase. , 2004, American journal of respiratory cell and molecular biology.

[11]  J. Major,et al.  Neutrophil chemoattractant genes KC and MIP‐2 are expressed in different cell populations at sites of surgical injury , 2004, Journal of leukocyte biology.

[12]  R. Sue,et al.  CXCR2 Is Critical to Hyperoxia-Induced Lung Injury1 , 2004, The Journal of Immunology.

[13]  R. Auten,et al.  Antimacrophage chemokine treatment prevents neutrophil and macrophage influx in hyperoxia-exposed newborn rat lung. , 2004, American journal of physiology. Lung cellular and molecular physiology.

[14]  K. Kaestner,et al.  Foxa2 regulates alveolarization and goblet cell hyperplasia , 2004, Development.

[15]  R. Baier,et al.  CC chemokine concentrations increase in respiratory distress syndrome and correlate with development of bronchopulmonary dysplasia , 2004, Pediatric pulmonology.

[16]  A. Choi American journal of respiratory cell and molecular biology: Introduction , 2003 .

[17]  J. Coalson Pathology of new bronchopulmonary dysplasia. , 2003, Seminars in neonatology : SN.

[18]  M. Burdick,et al.  Critical role for CXCR2 and CXCR2 ligands during the pathogenesis of ventilator-induced lung injury. , 2002, The Journal of clinical investigation.

[19]  R. Strieter,et al.  CXC chemokines in angiogenesis related to pulmonary fibrosis. , 2002, Chest.

[20]  A. Jobe,et al.  Decreased Indicators of Lung Injury with Continuous Positive Expiratory Pressure in Preterm Lambs , 2002, Pediatric Research.

[21]  D. Massaro,et al.  Lung alveoli: endogenous programmed destruction and regeneration. , 2002, American journal of physiology. Lung cellular and molecular physiology.

[22]  K. Geering,et al.  Human nongastric H+-K+-ATPase: transport properties of ATP1al1 assembled with different beta-subunits. , 2002, American journal of physiology. Cell physiology.

[23]  R. Watkins,et al.  Angiogenic factors and alveolar vasculature: development and alterations by injury in very premature baboons. , 2002, American journal of physiology. Lung cellular and molecular physiology.

[24]  R. Watkins,et al.  Disrupted pulmonary vasculature and decreased vascular endothelial growth factor, Flt-1, and TIE-2 in human infants dying with bronchopulmonary dysplasia. , 2001, American journal of respiratory and critical care medicine.

[25]  D. McDonald,et al.  Angiogenesis and remodeling of airway vasculature in chronic inflammation. , 2001, American journal of respiratory and critical care medicine.

[26]  J. White,et al.  Nonpeptide CXCR2 antagonist prevents neutrophil accumulation in hyperoxia-exposed newborn rats. , 2001, The Journal of pharmacology and experimental therapeutics.

[27]  Stark Ar 超出生体重児に対する早期デキサメサゾン投与の有用性 : National Institute of Child Health and Human Development Neonatal research Network報告 (海外誌掲載論文の和文概要とそれに対するコメント) , 2001 .

[28]  S. Abrams Chronic pulmonary insufficiency in children and its effects on growth and development. , 2001, The Journal of nutrition.

[29]  W. Poole,et al.  Adverse effects of early dexamethasone treatment in extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. , 2001, The New England journal of medicine.

[30]  R. Auten,et al.  Lung inflammation in hyperoxia can be prevented by antichemokine treatment in newborn rats. , 2000, American journal of respiratory and critical care medicine.

[31]  B. Yoder,et al.  High-frequency oscillatory ventilation: effects on lung function, mechanics, and airway cytokines in the immature baboon model for neonatal chronic lung disease. , 2000, American journal of respiratory and critical care medicine.

[32]  R. Bland,et al.  Chronic Lung Disease in Early Infancy , 2000 .

[33]  M. Keating,et al.  Impaired distal airway development in mice lacking elastin. , 2000, American journal of respiratory cell and molecular biology.

[34]  N. Voelkel,et al.  Inhibition of angiogenesis decreases alveolarization in the developing rat lung. , 2000, American journal of physiology. Lung cellular and molecular physiology.

[35]  J. Hauth,et al.  Intrauterine infection and preterm delivery. , 2000, The New England journal of medicine.

[36]  J. Tichelaar,et al.  Conditional Expression of Fibroblast Growth Factor-7 in the Developing and Mature Lung* , 2000, The Journal of Biological Chemistry.

[37]  W. Webb,et al.  High-resolution inspiratory and expiratory CT in older children and adults with bronchopulmonary dysplasia. , 1999, AJR. American journal of roentgenology.

[38]  B. Yoder,et al.  Neonatal chronic lung disease in extremely immature baboons. , 1999, American journal of respiratory and critical care medicine.

[39]  G. Verleden,et al.  Expression of monocyte chemotactic protein (MCP)-1, MCP-2, and MCP-3 by human airway smooth-muscle cells. Modulation by corticosteroids and T-helper 2 cytokines. , 1999, American journal of respiratory cell and molecular biology.

[40]  K. Osanai,et al.  Effects of interleukin‐1β on DNA synthesis in rat alveolar type II cells in primary culture , 1999 .

[41]  D. Carlton,et al.  Chronic lung injury in preterm lambs. Disordered respiratory tract development. , 1999, American journal of respiratory and critical care medicine.

[42]  P. Libby,et al.  Generation of Biologically Active IL-1β by Matrix Metalloproteinases: A Novel Caspase-1-Independent Pathway of IL-1β Processing , 1998, The Journal of Immunology.

[43]  K. Wenstrom,et al.  Elevated second-trimester amniotic fluid interleukin-6 levels predict preterm delivery. , 1998, American journal of obstetrics and gynecology.

[44]  B. Rollins,et al.  Abnormalities in Monocyte Recruitment and Cytokine Expression in Monocyte Chemoattractant Protein 1–deficient Mice , 1998, The Journal of experimental medicine.

[45]  C. Betsholtz,et al.  Alveogenesis failure in PDGF-A-deficient mice is coupled to lack of distal spreading of alveolar smooth muscle cell progenitors during lung development. , 1997, Development.

[46]  A. Hakulinen,et al.  Bronchial lability and responsiveness in school children born very preterm. , 1997, American journal of respiratory and critical care medicine.

[47]  F. Ghezzi,et al.  Amniotic fluid cytokines (interleukin-6, tumor necrosis factor-⍺, interleukin-1β, and interleukin-8) and the risk for the development of bronchopulmonary dysplasia , 1997 .

[48]  M. Hallman,et al.  Intraamniotic interleukin-1 accelerates surfactant protein synthesis in fetal rabbits and improves lung stability after premature birth. , 1997, The Journal of clinical investigation.

[49]  R. Pierce,et al.  Chronic lung injury in preterm lambs: disordered pulmonary elastin deposition. , 1997, The American journal of physiology.

[50]  S. Baron,et al.  Respiratory syncytial virus infection of human respiratory epithelial cells up-regulates class I MHC expression through the induction of IFN-beta and IL-1 alpha. , 1996, Journal of immunology.

[51]  M. Silverman,et al.  Increase in Interleukin (IL)-1β and IL-6 in Bronchoalveolar Lavage Fluid Obtained from Infants with Chronic Lung Disease of Prematurity , 1996, Pediatric Research.

[52]  C. Dinarello,et al.  Biologic basis for interleukin-1 in disease. , 1996, Blood.

[53]  K. Watterberg,et al.  Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops. , 1996, Pediatrics.

[54]  P. Proost,et al.  Human monocyte chemotactic proteins‐2 and ‐3: structural and functional comparison with MCP‐1 , 1996, Journal of leukocyte biology.

[55]  Armen B. Shanafelt,et al.  The Functional Role of the ELR Motif in CXC Chemokine-mediated Angiogenesis (*) , 1995, The Journal of Biological Chemistry.

[56]  M. Silverman,et al.  Increase in interleukin-8 and soluble intercellular adhesion molecule-1 in bronchoalveolar lavage fluid from premature infants who develop chronic lung disease. , 1995, Archives of disease in childhood. Fetal and neonatal edition.

[57]  J. Whitsett,et al.  SP-A deficiency in primate model of bronchopulmonary dysplasia with infection. In situ mRNA and immunostains. , 1995, American journal of respiratory and critical care medicine.

[58]  S. Shapiro,et al.  Elastolytic metalloproteinases produced by human mononuclear phagocytes. Potential roles in destructive lung disease. , 1994, American journal of respiratory and critical care medicine.

[59]  R. Romero,et al.  Interleukin‐1α and Interleukin‐1 β in Preterm and Term Human Parturition , 1992 .

[60]  E. S. Kimball,et al.  Angiogenesis in pannus formation , 1991, Agents and Actions.

[61]  S. Shapiro,et al.  Human 92- and 72-kilodalton type IV collagenases are elastases. , 1991, The Journal of biological chemistry.

[62]  K. Leslie,et al.  Alpha smooth muscle actin expression in developing and adult human lung. , 1990, Differentiation; research in biological diversity.

[63]  I. Hemo,et al.  In vivo angiogenic activity of interleukins. , 1990, Archives of ophthalmology.

[64]  B. Quednow,et al.  Influence of milk on the bioavailability of doxycycline — new aspects , 1989, Infection.

[65]  R. Guthrie,et al.  Early onset of airway reactivity in premature infants with bronchopulmonary dysplasia. , 1987, The American review of respiratory disease.

[66]  D. Strayer,et al.  Elastase and alpha 1-proteinase inhibitor activity in tracheal aspirates during respiratory distress syndrome. Role of inflammation in the pathogenesis of bronchopulmonary dysplasia. , 1983, The Journal of clinical investigation.

[67]  L. Monte,et al.  [Bronchopulmonary dysplasia]. , 2005, Jornal de pediatria.

[68]  J. Crapo,et al.  A catalytic antioxidant attenuates alveolar structural remodeling in bronchopulmonary dysplasia. , 2003, American journal of respiratory and critical care medicine.

[69]  K. Osanai,et al.  Effects of interleukin-1 beta on DNA synthesis in rat alveolar type II cells in primary culture. , 1999, Respirology.

[70]  P. Libby,et al.  Generation of biologically active IL-1 beta by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1 beta processing. , 1998, Journal of immunology.

[71]  F. Ghezzi,et al.  Amniotic fluid cytokines (interleukin-6, tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8) and the risk for the development of bronchopulmonary dysplasia. , 1997, American journal of obstetrics and gynecology.

[72]  R. Romero,et al.  Interleukin-1 alpha and interleukin-1 beta in preterm and term human parturition. , 1992, American journal of reproductive immunology.